Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY EBITDA

EBITDA at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$52.98M-147%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$1.62M-107%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$83.01M+14.0%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
——
Alkermes logo
AlkermesALKS
——
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
——

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

$37.3Mebit+
$6.0MDepreciation Depletion & Amortization
=$43.26M

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s EBITDA?
Harmony Biosciences Holdings, Inc. (HRMY) reported EBITDA of $43.26M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s EBITDA changed year-over-year?
Harmony Biosciences Holdings, Inc.'s EBITDA decreased by 30.5% year-over-year, from $62.21M to $43.26M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s EBITDA has grown at a 21.6% compound annual growth rate (CAGR), from $106.37M to $232.33M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.